United Therapeutics CEO Martine Rothblatt disposes of 9,595 common shares worth $4.98 million
Reuters2026/08/06 20:35- United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at USD 135.42 on Aug. 5.
- The related trust sold 9,494 shares in multiple trades, with reported prices ranging from USD 502.29 to USD 524.59.
- Trust holdings ended the day at 324,443 shares of common stock.
- The trust held 198,910 stock options following the transaction.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Today's Fear & Greed Index rises to 65, indicating the market is in a 'greed' state.
CFTC files motion to dismiss CME's motion regarding perpetual contracts lawsuit
At a sensitive moment of the "bond market storm," the market focuses on today's 30-year Japanese government bond auction.
Japan’s 30-year government bond yield has risen to 4.155%, approaching a historic high. The 30-year bond auction scheduled for Thursday is drawing significant attention. Analysts generally expect a weak result and warn that if the auction goes poorly, it could put reverse pressure on US Treasuries, prompting a repricing of the global fixed income market and potentially becoming a new trigger for rising global borrowing costs.
2-Yr Benchmark Govt Yields - Germany vs Other Nations
Crypto prices
More
